cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.14457/cu.the.2001.655
title: ผลการสอนโดยใช้กิจกรรมตามแนวคิดนีโอฮิวแมนนิสต่อการเห็นคุณค่าในตนเองของผู้สูงอายุหญิงในสถานสงเคราะห์

description: การวิจัยครั้งนี้ มีวัตถุประสงค์เพื่อศึกษาผลของการสอนโดยใช้กิจกรรมนีโอฮิวแมนนิสต่อการเห็นคุณค่าในตนเองของผู้สูงอายุหญิงในสถานสงเคราะห์ โดยมีสมมุติฐานของการวิจัยว่าการเห็นคุณค่าในตนเองของผู้สูงอายุหญิงหลังการสอนโดยใช้กิจกรรมตามแนวคิดนีโอฮิวแมนนิสสูงกว่าก่อนการสอน ใช้การวิจัยแบบ pre-experimental design แบบกลุ่มเดียว วัด 3 ครั้ง โดยทำการวัดก่อนการทดลอง 2 ครั้งห่างกัน 4 สัปดาห์ และหลังการทดลอง 1 ครั้ง หลังจากกลุ่มตัวอย่างได้รับการสอนโดยใช้กิจกรรมตามแนวคิดนีโอฮิวแมนนิส เป็นเวลา 4 สัปดาห์ กลุ่มตัวอย่างเป็นผู้สูงอายุหญิงในสถานสงเคราะห์คนชราสยามราชกุมารี (หลวงพ่อเปิ่นอุปถัมภ์) อ.นครชัยศรี จ.นครปฐม ที่ผ่านเกณฑ์การคัดเลือก รวมทั้งสิ้น 22 ราย เข้าร่วมกิจกรรมการสอนตามแนวคิดนีโอฮิวแมนนิส ซึ่งได้แก่ การฝึกโยคะอาสนะ การผ่อนคลาย การฝึกสมาธิ และการบรรยายความรู้เครื่องมือที่ใช้ในการวิจัย ได้แก่ แบบวัดการเห็นคุณค่าในตนเอง แบบสัมภาษณ์ความรู้สึกหลังการเข้าร่วมกิจกรรม และแผนการสอนโดยใช้กิจกรรมตามแนวคิดนีโอฮิวแมนนิส วิเคราะห์ข้อมูลโดยการทดสอบความแตกต่างของค่าคะแนนเฉลี่ยการเห็นคุณค่าในตนเอง ด้วยวิธีการทดสอบค่าที ส่วนการวิเคราะห์ข้อมูลที่ได้จากการสัมภาษณ์ นำข้อมูลมาวิเคราะห์เนื้อหา และสรุปเป็นประเด็นที่เกี่ยวกับผลการฝึกกิจกรรมตามแนวคดนีโอฮิวแมนนิส ผลการวิจัยพบว่า 1. การเห็นคุณค่าในตนเองของผู้สูงอายุจากการวัด 2 ครั้งก่อนการทดลองห่างกัน 4 สัปดาห์มีคะแนนการเห็นคุณค่าในตนเองไม่แตกต่างกันอย่างมีนัยสำคัญทางสถิติ 2. การเห็นคุณค่าในตนเองของผู้สูงอายุหลังการทดลองสูงกว่าก่อนการทดลอง อย่างมีนัยสำคัญทางสถิติที่ระดับ .05
DOI: 10.6084/m9.figshare.19801444.v1
title: Additional file 1 of Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment

description: Additional file 1: Workbook S1. DCX, COMT, and FMR1 hippocampal gene correlates.
DOI: 10.6084/m9.figshare.19801447.v1
title: Additional file 2 of Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment

description: Additional file 2: Workbook S2. Gene Ontology analysis of DCX, COMT, and FMR1 hippocampal gene correlates.
DOI: 10.6084/m9.figshare.19801444
title: Additional file 1 of Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment

description: Additional file 1: Workbook S1. DCX, COMT, and FMR1 hippocampal gene correlates.
DOI: 10.6084/m9.figshare.19801447
title: Additional file 2 of Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment

description: Additional file 2: Workbook S2. Gene Ontology analysis of DCX, COMT, and FMR1 hippocampal gene correlates.
DOI: 10.6084/m9.figshare.19801450
title: Additional file 3 of Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment

description: Additional file 3: Workbook S3. DCX, COMT, and FMRP protein–protein interaction network.
DOI: 10.6084/m9.figshare.19801453
title: Additional file 4 of Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment

description: Additional file 4: Workbook S4. DCX, COMT, and FMR1 functional enrichment categories for neurogenesis genes.
DOI: 10.6084/m9.figshare.19801450.v1
title: Additional file 3 of Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment

description: Additional file 3: Workbook S3. DCX, COMT, and FMRP protein–protein interaction network.
DOI: 10.6084/m9.figshare.19801453.v1
title: Additional file 4 of Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment

description: Additional file 4: Workbook S4. DCX, COMT, and FMR1 functional enrichment categories for neurogenesis genes.
DOI: 10.6084/m9.figshare.19771534
title: QALY and YLL due to Covid-19 in West Bengal.xlsx

description: QALYs Associated with Covid-19 Deaths in West Bengal
DOI: 10.6084/m9.figshare.19771534.v1
title: QALY and YLL due to Covid-19 in West Bengal.xlsx

description: QALYs Associated with Covid-19 Deaths in West Bengal
DOI: 10.6084/m9.figshare.19801459
title: Participants' Demographic Information.docx

description: Participants' demographic information from a published nationwide study examining public perceptions towards LGBT in Malaysia.
DOI: 10.25934/pr00005284.1
title: Available IPD datapackage for study 'A Multicentre, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures (Extension of Study RTG114855)'

description: This is a multicentre, long-term, open-label extension (OLE) study to assess the long-term safety, tolerability and efficacy of retigabine immediate-release (IR) as adjunctive therapy in adult Asian subjects with drug-resistant partial-onset seizures (POS).
DOI: 10.25934/pr00005283.1
title: Available IPD datapackage for study 'A Multicentre, Open-Label, Long-Term, Safety and Tolerability Study of Retigabine Immediate Release (IR) in Adults With Partial-Onset Seizures (Extension of Study RGB113905)'

description: The purpose of this Phase III study is to assess the long-term safety, tolerability and efficacy of flexibly dosed retigabine Immediate Release (IR) as adjunctive therapy in adult subjects with partial-onset seizures. In addition, those subjects who successfully completed 20 weeks of adjunctive treatment with retigabine IR in the parent study, RGB113905, and who were thought to have benefitted from treatment will be provided continued access to retigabine IR.
DOI: 10.6084/m9.figshare.19801477
title: Participants' Views of LGBT

description: Participants' views of LGBT were from a published nationwide study examining public perceptions of LGBT in Malaysia.
DOI: 10.34740/kaggle/dsv/3666780
title: Contrastive Language Image Pretraining by openai
DOI: 10.25934/pr00000265.0
title: Data Package for study.

description: Pharmacokinetic (PK) study to characterize changes in serum concentrations in epilepsy patients when switching from LAMICTAL immediate-release to extended-release and vice versa.
DOI: 10.6084/m9.figshare.19801501
title: Supplementary Material for: Clinical Characteristics, Health Care Resource Utilization, and Prescription Patterns of Japanese Patients with Physician-Diagnosed Allergic Rhinitis: A Secondary Use of Database Study

description: <b><i>Introduction:</i></b> Allergic rhinitis (AR) is associated with a substantial health care burden. In Japan, clinical patient profiles in real-life settings and evidence on economic burden of AR are limited. We studied clinical characteristics of patients with AR in Japan, and their impact on health care resource utilization (HCRU) and associated costs. <b><i>Methods:</i></b> This was a noninterventional study in patients aged ≥2 years with ≥2 physician-diagnosed AR, from a Japanese Claims Database, conducted from 2009 to 2018. The study comprised 6 cohorts; 1 primary, 3 secondary (cohorts 1, 2, 2-s), and 2 comparison cohorts 1 and 2-s (matched surgery and non-surgery). The primary objective was to describe demographic and clinical characteristics of patients in primary cohort. The secondary objectives were assessment of demographic and clinical characteristics in secondary cohorts and comparison of HCRU-related variables and allergic comorbidities between comparison cohorts. <b><i>Results:</i></b> Of 5,260,253 subjects data retrieved, 879,348 were included in primary cohort, with demographics and clinical characteristics being consistent across study period. Most frequent AR-related comorbidities were allergic conjunctivitis (41.7%) and asthma (38.6%). By 2018, 4,246 patients were included in secondary cohort 1, 866,453 in secondary cohort 2, 258,855 in secondary cohort 2-s, 3,496 in comparison cohort 1, and 13,984 in comparison cohort 2-s. Monthly HCRU-related variables between comparison cohort 1 and comparison 2-s indicated that AR-related surgeries and prescriptions peaked in prepollen and pollen seasons, respectively. HCRU and related costs were comparable but slightly higher in surgery than in non-surgery cohort. <b><i>Conclusion:</i></b> Real-world evidence of patients with AR highlights the need for cost-effective health care with opportunities for developing novel therapies.
DOI: 10.6084/m9.figshare.19801501.v1
title: Supplementary Material for: Clinical Characteristics, Health Care Resource Utilization, and Prescription Patterns of Japanese Patients with Physician-Diagnosed Allergic Rhinitis: A Secondary Use of Database Study

description: <b><i>Introduction:</i></b> Allergic rhinitis (AR) is associated with a substantial health care burden. In Japan, clinical patient profiles in real-life settings and evidence on economic burden of AR are limited. We studied clinical characteristics of patients with AR in Japan, and their impact on health care resource utilization (HCRU) and associated costs. <b><i>Methods:</i></b> This was a noninterventional study in patients aged ≥2 years with ≥2 physician-diagnosed AR, from a Japanese Claims Database, conducted from 2009 to 2018. The study comprised 6 cohorts; 1 primary, 3 secondary (cohorts 1, 2, 2-s), and 2 comparison cohorts 1 and 2-s (matched surgery and non-surgery). The primary objective was to describe demographic and clinical characteristics of patients in primary cohort. The secondary objectives were assessment of demographic and clinical characteristics in secondary cohorts and comparison of HCRU-related variables and allergic comorbidities between comparison cohorts. <b><i>Results:</i></b> Of 5,260,253 subjects data retrieved, 879,348 were included in primary cohort, with demographics and clinical characteristics being consistent across study period. Most frequent AR-related comorbidities were allergic conjunctivitis (41.7%) and asthma (38.6%). By 2018, 4,246 patients were included in secondary cohort 1, 866,453 in secondary cohort 2, 258,855 in secondary cohort 2-s, 3,496 in comparison cohort 1, and 13,984 in comparison cohort 2-s. Monthly HCRU-related variables between comparison cohort 1 and comparison 2-s indicated that AR-related surgeries and prescriptions peaked in prepollen and pollen seasons, respectively. HCRU and related costs were comparable but slightly higher in surgery than in non-surgery cohort. <b><i>Conclusion:</i></b> Real-world evidence of patients with AR highlights the need for cost-effective health care with opportunities for developing novel therapies.
DOI: 10.6084/m9.figshare.19801486
title: Factors Influencing Participants' Views of LGBT

description: Factors Influencing participants' views of LGBT were taken from a nationwide study examining public perceptions of LGBT in Malaysia.
DOI: 10.6084/m9.figshare.19801486.v1
title: Factors Influencing Participants' Views of LGBT

description: Factors Influencing participants' views of LGBT were taken from a nationwide study examining public perceptions of LGBT in Malaysia.
DOI: 10.6084/m9.figshare.19549495.v1
title: Divergent evolution in Candidatus Nanohaloarchaeota

description: These are the raw data and scripts for the manuscript "<strong>Nanoanaerosalinaceae reveals divergent evolution in Nanohaloarchaeota</strong>".
DOI: 10.5281/zenodo.6565706
title: Ground-Truthed Data Set of Zenon Papyri for Handwritten Text Recognition

description: Diplomatic transcription of papyri found in the Zenon archive [see en.wikipedia.org/wiki/Zenon_of_Kaunos] Manually prepared as PageXML with Transkribus within D-Scribes project.
DOI: 10.5281/zenodo.6565705
title: Ground-Truthed Data Set of Zenon Papyri for Handwritten Text Recognition

description: Diplomatic transcription of papyri found in the Zenon archive [see en.wikipedia.org/wiki/Zenon_of_Kaunos] Manually prepared as PageXML with Transkribus within D-Scribes project.
DOI: 10.25345/c59k45x39
title: MassIVE MSV000089500 - FBP1 immunoprecipitants of Huh7 cells and FBP1 immunoprecipitants of L02 cells upon glucose deprivation
title: this file contain 2 raw data: FBP1 immunoprecipitants of Huh7 cells and FBP1 immunoprecipitants of LO2 cells upon glucose deprivation
DOI: 10.5517/ccdc.csd.cc26hpm1
title: CCDC 2040873: Experimental Crystal Structure Determination

description: Related Article: Zhenghan Jiang, Lingling Gao, Yujuan Zhang, Tuoping Hu|2022|Inorg.Chem.Commun.|141|109534|doi:10.1016/j.inoche.2022.109534
DOI: 10.5517/ccdc.csd.cc26hpn2
title: CCDC 2040874: Experimental Crystal Structure Determination

description: Related Article: Zhenghan Jiang, Lingling Gao, Yujuan Zhang, Tuoping Hu|2022|Inorg.Chem.Commun.|141|109534|doi:10.1016/j.inoche.2022.109534
DOI: 10.5517/ccdc.csd.cc292zjx
title: CCDC 2118029: Experimental Crystal Structure Determination

description: Related Article: Nicolas I. Regenauer, Hubert Wadepohl, Dragoş-Adrian Roşca|2022|Inorg.Chem.|61|7426|doi:10.1021/acs.inorgchem.2c00459
DOI: 10.5517/ccdc.csd.cc292zky
title: CCDC 2118030: Experimental Crystal Structure Determination

description: Related Article: Nicolas I. Regenauer, Hubert Wadepohl, Dragoş-Adrian Roşca|2022|Inorg.Chem.|61|7426|doi:10.1021/acs.inorgchem.2c00459
DOI: 10.5517/ccdc.csd.cc292zlz
title: CCDC 2118031: Experimental Crystal Structure Determination

description: Related Article: Nicolas I. Regenauer, Hubert Wadepohl, Dragoş-Adrian Roşca|2022|Inorg.Chem.|61|7426|doi:10.1021/acs.inorgchem.2c00459
DOI: 10.5517/ccdc.csd.cc292zm0
title: CCDC 2118032: Experimental Crystal Structure Determination

description: Related Article: Nicolas I. Regenauer, Hubert Wadepohl, Dragoş-Adrian Roşca|2022|Inorg.Chem.|61|7426|doi:10.1021/acs.inorgchem.2c00459
DOI: 10.5517/ccdc.csd.cc292zn1
title: CCDC 2118033: Experimental Crystal Structure Determination

description: Related Article: Nicolas I. Regenauer, Hubert Wadepohl, Dragoş-Adrian Roşca|2022|Inorg.Chem.|61|7426|doi:10.1021/acs.inorgchem.2c00459
DOI: 10.5517/ccdc.csd.cc292zp2
title: CCDC 2118034: Experimental Crystal Structure Determination

description: Related Article: Nicolas I. Regenauer, Hubert Wadepohl, Dragoş-Adrian Roşca|2022|Inorg.Chem.|61|7426|doi:10.1021/acs.inorgchem.2c00459
DOI: 10.5517/ccdc.csd.cc292zq3
title: CCDC 2118035: Experimental Crystal Structure Determination

description: Related Article: Nicolas I. Regenauer, Hubert Wadepohl, Dragoş-Adrian Roşca|2022|Inorg.Chem.|61|7426|doi:10.1021/acs.inorgchem.2c00459
DOI: 10.5517/ccdc.csd.cc292zr4
title: CCDC 2118036: Experimental Crystal Structure Determination

description: Related Article: Nicolas I. Regenauer, Hubert Wadepohl, Dragoş-Adrian Roşca|2022|Inorg.Chem.|61|7426|doi:10.1021/acs.inorgchem.2c00459
DOI: 10.5517/ccdc.csd.cc297bfb
title: CCDC 2122211: Experimental Crystal Structure Determination

description: Related Article: Mengjiao Kong, Feifei Xing, Shourong Zhu|2022|Inorg.Chem.Commun.|141|109530|doi:10.1016/j.inoche.2022.109530
DOI: 10.5517/ccdc.csd.cc297bgc
title: CCDC 2122212: Experimental Crystal Structure Determination

description: Related Article: Mengjiao Kong, Feifei Xing, Shourong Zhu|2022|Inorg.Chem.Commun.|141|109530|doi:10.1016/j.inoche.2022.109530
DOI: 10.5517/ccdc.csd.cc29bf58
title: CCDC 2125179: Experimental Crystal Structure Determination

description: Related Article: Lea Gimeno, Brian T. Phelan, Emily A. Sprague-Klein, Thierry Roisnel, Errol Blart, Christophe Gourlaouen, Lin X. Chen, Yann Pellegrin|2022|Inorg.Chem.|61|7296|doi:10.1021/acs.inorgchem.1c03901
DOI: 10.6084/m9.figshare.19801567
title: Supplementary Material for: Waning of SARS-CoV-2 Vaccine-Induced Immune Response over 6 Months in Peritoneal Dialysis Patients and the Role of a Booster Dose in Maintaining Seropositivity

description: <b><i>Introduction:</i></b> Although lower than general population, newly developed SARS-CoV-2 vaccines generate immune responses in end-stage kidney disease patients. However, the persistence of immune responses in the long term is not known yet. This study aimed to evaluate humoral immune responses in peritoneal dialysis (PD) patients over 6 months and to analyze the effects of the booster dose. <b><i>Methods:</i></b> Humoral immune responses of PD patients were measured after initial SARS-CoV-2 vaccinations and after 6 months following initial vaccinations. Immune responses were compared between patients who received and did not receive booster doses. PD patients were compared with 41 hemodialysis (HD) patients and 61 healthy controls. Humoral immune responses were measured by a commercial test that detects antibodies toward the receptor-binding domain of the spike protein of SARS-CoV-2. <b><i>Results:</i></b> Twenty PD patients were evaluated over 6 months. The initial seropositivity rate was 90.9% with inactivated vaccine and 100% with mRNA vaccine. Seropositivity decreased to 44.4% after 6 months, and a booster dose helped in maintaining the 100% of seropositivity (<i>p</i> = 0.005). Magnitude of humoral response at the 6th month was also higher in patients who received the third dose (1,132.8 ± 769.6 AU/mL vs. 400.0 ± 294.6 AU/mL; <i>p</i> = 0.015). Among patients who did not receive the third dose, those who got mRNA vaccine could maintain higher seropositivity than others who got inactivated vaccine (75% vs. 40% for PD, 81.8% vs. 50% for HD). Seropositivity and antibody levels were similar for PD and HD patients after 6 months (<i>p</i> = 0.24 and 0.56) but lower than healthy controls (<i>p</i> = 0.0013). <b><i>Conclusion:</i></b> SARS-CoV-2 vaccine-induced antibody levels and seropositivity of PD patients significantly fall after 6 months. A booster dose after around 3 months following initial immunization might help in maintaining seropositivity.
DOI: 10.6084/m9.figshare.19801513
title: Supplementary Material for: Influence of Estradiol-Producing Ovarian Tumors on the Maturation Index of Cervical Cytology in Postmenopausal Women

description: <b><i>Introduction:</i></b> The aim of the study was to evaluate the influence of estradiol-producing ovarian tumors, including surface epithelial-stromal tumors, on the cervical cytology of postmenopausal women. <b><i>Methods:</i></b> This case-controlled study included 160 postmenopausal women who underwent a gynecological surgery between January 2009 and December 2016. The relationship between serum estradiol levels and the maturation index of cervical cytology was examined. Patients with ovarian tumors and a high estradiol level (≥28 pg/mL) constituted the estradiol-producing ovarian tumor group (30 women, including 23 with surface epithelial-stromal tumors). The maturation index of this group was compared with that of the control group (130 women with normal estradiol levels [&lt;28 pg/mL] with either ovarian tumors or uterine tumors). <b><i>Results:</i></b> For all patients, the serum estradiol levels were significantly correlated with the maturation index (<i>p</i> &lt; 0.001, <i>r</i> = 0.65). The maturation index of the estradiol-producing ovarian tumor group was significantly higher than that of the control group (0.67 ± 0.21 vs. 0.075 ± 0.16, <i>p</i> &lt; 0.001). The area under the receiver operating characteristic curve for the maturation index was 0.94. The best maturation index cut-off level for estradiol-producing ovarian tumors was 0.20. Using this cut-off, the sensitivity and specificity were 94% and 82%, respectively. <b><i>Conclusion:</i></b> Estradiol-producing ovarian tumors influence cervical epithelial maturation in postmenopausal women. An increased maturation index may trigger the early detection of asymptomatic ovarian tumors.
DOI: 10.23708/u9gr0c
title: Location and morphological status of spring mounds in the Nefzaoua Province in western Tunisia in 2020.

description: This dataset holds the location and the morphological characteristics of spring mounds in the Nefzaoua Province (governorate of Kebili) in western Tunisia. Overall, in an area of 3 000 km2, 126 spring mounds of 7 types were identified, of which 112 (89%) were degraded. Due to the low salt content in spring mound sediments, they are excavated and used as a soil amendment to expand new palm plantations. Only 14 mounds (11%) are presently preserved. We used old topographical maps, aerial photographs, TanDEM-X digital elevation model (DEM) and information from Google Earth to create this dataset.
DOI: 10.6084/m9.figshare.19801636
title: Supplementary Material for: Germline-Restricted Chromosomes and Autosomal Variants Revealed by Pachytene Karyotyping of 17 Avian Species

description: Karyotypes of less than 10% of bird species are known. Using immunolocalization of the synaptonemal complex, the core structure of meiotic chromosomes at the pachytene stage, and centromere proteins, we describe male pachytene karyotypes of 17 species of birds. This method enables higher resolution than the conventional analyses of metaphase chromosomes. We provide the first descriptions of the karyotypes of 3 species (rook, Blyth’s reed warbler, and European pied flycatcher), correct the published data on the karyotypes of 10 species, and confirm them for 4 species. All passerine species examined have highly conservative karyotypes, 2n = 80–82 with 7 pairs of macrochromosomes (including the ZZ sex chromosome pair which was not unambiguously distinguished from other macrochromosomes in most species) and 33–34 pairs of microchromosomes. In all of them, but not in the common cuckoo, we revealed single copies of the germline-restricted chromosomes varying in size and morphology even between closely related species. This indicates a fast evolution of this additional chromosome. The interspecies differences concern the sizes of the macrochromosomes, morphology of the microchromosomes, and sizes of the centromeres. The pachytene cells of the gouldian finch, brambling, and common linnet contain heteromorphic synaptonemal complexes indicating heterozygosity for inversions or centromere shifts. The European pied flycatcher, gouldian finch, and domestic canary have extended centromeres in several macro- and microchromosomes.
DOI: 10.6084/m9.figshare.19801630
title: Supplementary Material for: Early Physiological and Adrenal Effects of Budesonide Mixed with Surfactant in Large Observational Preterm Cohort Study

description: <b><i>Background:</i></b> The combination of surfactant and budesonide has been shown to decrease BPD rates and severity. Budesonide may be released systemically from lungs, and the effects on the immature adrenal glands are not known. <b><i>Objective:</i></b> The aim of this study was to determine if adrenal suppression rates are higher in preterm infants receiving budesonide with surfactant compared to surfactant alone. <b><i>Methods:</i></b> A retrospective chart review of 608 infants ≤1,250 g received intubation for surfactant therapy from 2013 through 2020. In August 2016, budesonide was added to surfactant for these infants. Indicators of adrenal suppression, including mean blood pressures, plasma electrolyte levels, hydrocortisone use, and the use of vasoactive medications, were analyzed for the first 14 days after birth. Respiratory variables, biochemical signs of adrenal insufficiency, and neonatal morbidities were analyzed. <b><i>Results:</i></b> There was no difference in hydrocortisone administration in the first 14 days between infants receiving budesonide with surfactant (<i>n</i> = 314) or surfactant alone (<i>n</i> = 294) (23% vs. 19%, <i>p</i> = 0.38). Budesonide exposed infants received hydrocortisone 3 days later than surfactant only infants (median DOL 5 vs. 2, <i>p</i> &lt; 0.001). Infants receiving budesonide had higher blood pressures, required less dopamine (19% vs. 39%, <i>p</i> &lt; 0.001) and dobutamine (2% vs. 6%, <i>p</i> = 0.02). Budesonide exposed infants were discharged home after a shorter NICU stay (85 days vs. 94 days, <i>p</i> = 0.02) and at a younger gestational age (39 vs. 40 weeks, <i>p</i> = 0.001). <b><i>Conclusions:</i></b> The use of surfactant and budesonide does not alter the rate of hydrocortisone use, but does delay the timing of treatment initiation and decreases the use of vasoactive medications.